查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1824603

2025年全球心臟AI監測與診斷市場報告

Cardiac AI Monitoring And Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年心臟人工智慧監測和診斷市場將呈指數級成長，到2029年將達到54.8億美元，複合年成長率為26.4%。預測期內的成長歸因於穿戴式裝置和物聯網設備的擴展、遠端醫療和遠端監控的日益普及、巨量資料分析和預測模型的整合、對以患者為中心的護理和遠距病人參與的重視，以及醫療基礎設施的發展。預測期內的主要趨勢包括穿戴式裝置與人工智慧的整合、個人化風險評估和治療計劃、心血管事件的預測分析、多模態資料來源的整合以及互通性和資料整合標準。

未來五年26.4%的成長率預測比我們先前的預測略有下降，下降了0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。關稅上漲可能會增加來自芬蘭和愛沙尼亞的人工智慧(AI)心電圖(ECG)分析儀和穿戴式心律不整檢測器的成本，從而加劇心血管疾病的管理成本，從而給美國心臟病學帶來壓力。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，關稅上漲的影響也可能更加廣泛。

心血管疾病 (CVD) 盛行率的上升預計將推動心臟 AI 監測和診斷市場的成長。 CVD 包括影響心臟和血管的各種疾病，例如腦血管心臟疾病和風濕性心臟疾病。心臟 AI 監測和診斷有助於心血管疾病的早期診斷、風險評估和個人化治療，從而改善患者的預後。例如，根據英國心血管研究慈善機構英國心臟基金會的數據，截至 2024 年 9 月，英國約有 760 萬人患有心臟和循環系統疾病，其中包括約 400 萬名男性和 360 萬名女性。這些疾病約佔英國所有死亡人數的 27%，每年超過 17 萬人死亡，每天約 480 人死亡，或每三分鐘就有一人死亡。因此，心血管疾病盛行率的上升正在刺激心臟 AI 監測和診斷市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球心臟人工智慧監測與診斷：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球心臟人工智慧監測與診斷市場：成長率分析
  • 全球心臟人工智慧監測與診斷市場表現：規模與成長，2019-2024
  • 全球心臟人工智慧監測與診斷市場預測：規模與成長，2024-2029 年，2034 年
  • 全球心臟人工智慧監測與診斷：總潛在市場（TAM）

第6章 市場細分

  • 全球心臟人工智慧監測和診斷市場：按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 心臟診斷
  • 心臟監測
  • 全球心臟人工智慧監測與診斷市場：按產品、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 軟體
  • 硬體
  • 全球心臟人工智慧監測和診斷市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 缺血性心臟疾病或冠狀動脈疾病（CAD）
  • 心律不整
  • 缺血性中風
  • 其他用途
  • 全球心臟人工智慧監測和診斷市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診斷中心
  • 其他最終用戶
  • 全球心臟人工智慧監測和診斷市場：按心臟診斷（類型）、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 心電圖分析
  • 心臟超音波圖檢查分析
  • 心臟影像
  • 生物標記分析
  • 全球心臟人工智慧監測和診斷市場：按心臟監測類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 穿戴式心電圖監測儀
  • 遠端患者監護系統
  • 植入式心臟裝置
  • 連續心電圖監測系統

第7章 區域和國家分析

  • 全球心臟人工智慧監測與診斷市場：區域表現與預測（2019-2024 年、2024-2029 年及 2034 年）
  • 全球心臟人工智慧監測與診斷市場：國家、績效及預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 心臟人工智慧監測與診斷市場：競爭格局
  • 心臟人工智慧監測和診斷市場：公司簡介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Boston Scientific Corporation
  • ZOLL Medical Corporation
  • Canon Medical Systems Corporation
  • Biotronik SE & Co. KG
  • iRhythm Technologies Inc.
  • Tempus Labs Inc.
  • Viz.ai Inc.
  • HeartFlow Inc.
  • Aidoc
  • Eko Devices Inc.
  • CardioFocus Inc.
  • Circle Cardiovascular Imaging Inc.
  • Ultromics Limited.
  • Cathworks
  • Medicalgorithmics SA

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年心臟 AI 監測與診斷市場：提供新機會的國家
  • 2029 年心臟 AI 監測與診斷市場：細分市場將帶來新機會
  • 2029年心臟AI監測與診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r27627u

Cardiac AI monitoring and diagnostics involve the application of artificial intelligence (AI) technologies in the field of cardiology to monitor and diagnose various cardiovascular conditions. This utilizes advanced algorithms and machine learning techniques to analyze data from cardiac monitoring devices, such as electrocardiograms (ECGs).

The main categories of cardiac AI monitoring and diagnostics are cardiac diagnostics and cardiac monitoring. Cardiac diagnostics encompass methods and procedures used to identify heart conditions associated with unhealthy or pathologic heart function. The products in this category include software and hardware used in applications such as ischemic heart diseases or coronary artery disease (CAD), cardiac arrhythmias, ischemic stroke, and others. End users of these cardiac AI solutions include hospitals, diagnostic centers, and various healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The cardiac AI monitoring and diagnostics research report is one of a series of new reports from The Business Research Company that provides cardiac AI monitoring and diagnostics market statistics, including the cardiac AI monitoring and diagnostics industry's global market size, regional shares, competitors with an cardiac AI monitoring and diagnostics market share, detailed cardiac AI monitoring and diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac AI monitoring and diagnostics industry. This cardiac AI monitoring and diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cardiac ai monitoring and diagnostics market size has grown exponentially in recent years. It will grow from $1.71 billion in 2024 to $2.14 billion in 2025 at a compound annual growth rate (CAGR) of 25.6%. The growth in the historic period can be attributed to aging population demographics, rise in remote patient monitoring, increased healthcare expenditure, clinical research and validation studies, focus on preventive healthcare.

The cardiac ai monitoring and diagnostics market size is expected to see exponential growth in the next few years. It will grow to $5.48 billion in 2029 at a compound annual growth rate (CAGR) of 26.4%. The growth in the forecast period can be attributed to expansion of wearable and IoT devices, increasing adoption of telemedicine and remote monitoring, integration of big data analytics and predictive modeling, focus on patient-centered care and remote patient engagement, healthcare infrastructure development. Major trends in the forecast period include integration of AI with wearable devices, personalized risk assessment and treatment planning, predictive analytics for cardiovascular events, integration of multimodal data sources, interoperability and data integration standards.

The forecast of 26.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. cardiology by driving up the cost of Artificial intelligence(AI)-powered Electrocardiogram(ECG) analyzers and wearable arrhythmia detectors sourced from Finland and Estonia, exacerbating cardiovascular disease management costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of cardiovascular diseases (CVDs) is expected to drive growth in the cardiac AI monitoring and diagnostics market. CVDs encompass a range of conditions affecting the heart and blood vessels, including cerebrovascular disease, coronary heart disease, and rheumatic heart disease. Cardiac AI monitoring and diagnostics facilitate early diagnosis, risk assessment, and personalized treatment for cardiovascular conditions, improving patient outcomes. For example, in September 2024, data from the British Heart Foundation, a UK-based cardiovascular research charity, indicated that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, with around 4 million men and 3.6 million women affected. These diseases account for about 27% of all deaths in the UK, resulting in over 170,000 deaths annually, or about 480 deaths per day, equivalent to one death every three minutes. Consequently, the increasing incidence of cardiovascular diseases is fueling growth in the cardiac AI monitoring and diagnostics market.

Leading companies operating in the cardiac AI monitoring and diagnostics market are directing their efforts towards the development of technology-driven medical devices, such as artificial intelligence-based implantable cardiac monitors, to solidify their position in the market. Artificial intelligence-based implantable cardiac monitors represent a groundbreaking innovation in cardiovascular healthcare, offering continuous and accurate monitoring of cardiac function. For example, in May 2023, Biotronik, a renowned cardiovascular biomedical research and technology company based in Germany, announced the FDA approval of its BIOMONITOR IV implantable cardiac monitor (ICM). Equipped with BIOTRONIK's cutting-edge SmartECG algorithm powered by artificial intelligence, the BIOMONITOR IV ICM sets a new standard in cardiac monitoring accuracy. By leveraging advanced algorithms, the SmartECG technology significantly reduces false identifications while maintaining a high detection rate for genuine cardiac episodes. This enhancement in detection accuracy empowers healthcare professionals to make prompt and precise diagnoses, thus optimizing patient care and outcomes. Furthermore, the BIOMONITOR IV ICM distinguishes between different types of cardiac contractions, such as premature ventricular contractions (PVCs) and premature atrial contractions (PACs), further enhancing its diagnostic capabilities and clinical utility.

In January 2022, Koninklijke Philips N.V., a healthcare technology company headquartered in the Netherlands, completed the acquisition of Cardiologs Technologies SAS, a medical technology company based in France, for an undisclosed sum. This strategic move positions Cardiologs to enhance Philips' cardiac monitoring and diagnostics portfolio through the integration of innovative software solutions, electrocardiogram (ECG) analysis, and reporting services. Cardiologs Technologies SAS specializes in optimizing cardiac diagnostics through the utilization of artificial intelligence (AI) and cloud technologies, aligning with Philips' commitment to advancing healthcare through cutting-edge innovations.

Major companies operating in the cardiac ai monitoring and diagnostics market report are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, ZOLL Medical Corporation, Canon Medical Systems Corporation, Biotronik SE & Co. KG, iRhythm Technologies Inc., Tempus Labs Inc., Viz.ai Inc., HeartFlow Inc., Aidoc, Eko Devices Inc., CardioFocus Inc., Circle Cardiovascular Imaging Inc., Ultromics Limited., Cathworks, Medicalgorithmics S.A., Nanox.AI Ltd, Cardiac Insight Inc., CardioSecur GmbH, Cardionomic Inc., HeartSciences, CardioComm Solutions Inc., CardioDiagnostics Inc.

North America was the largest region in the cardiac AI monitoring and diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac ai monitoring and diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac ai monitoring and diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiac AI monitoring and diagnostics market consists of revenues earned by entities by providing services such as ST-segment monitoring, arrhythmia detection, heart rate variability analysis, risk stratification, and echocardiogram interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac AI monitoring and diagnostics market also includes sales of echocardiography devices, cardiac MRI and CT analysis, electrocardiogram (ECG) analysis tools, and wearable devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac AI Monitoring And Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac ai monitoring and diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac ai monitoring and diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac ai monitoring and diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Cardiac Diagnostics; Cardiac Monitoring
  • 2) By Product: Software; Hardware
  • 3) By Application: Ischemic Heart Diseases Or Coronary Artery Disease (CAD); Cardiac Arrhythmias; Ischemic Stroke; Other Applications
  • 4) By End Users: Hospitals; Diagnostic Centers; Other End Users
  • Subsegments:
  • 1) By Cardiac Diagnostics: ECG Analysis; Echocardiography Analysis; Cardiac Imaging; Biomarker Analysis
  • 2) By Cardiac Monitoring: Wearable Cardiac Monitors; Remote Patient Monitoring Systems; Implantable Cardiac Devices; Continuous ECG Monitoring Systems
  • Companies Mentioned: Abbott Laboratories; Medtronic plc; Siemens Healthineers AG; Koninklijke Philips N.V.; GE HealthCare Technologies Inc.; Boston Scientific Corporation; ZOLL Medical Corporation; Canon Medical Systems Corporation; Biotronik SE & Co. KG; iRhythm Technologies Inc.; Tempus Labs Inc.; Viz.ai Inc.; HeartFlow Inc.; Aidoc; Eko Devices Inc.; CardioFocus Inc.; Circle Cardiovascular Imaging Inc.; Ultromics Limited.; Cathworks; Medicalgorithmics S.A.; Nanox.AI Ltd; Cardiac Insight Inc.; CardioSecur GmbH; Cardionomic Inc.; HeartSciences; CardioComm Solutions Inc.; CardioDiagnostics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac AI Monitoring And Diagnostics Market Characteristics

3. Cardiac AI Monitoring And Diagnostics Market Trends And Strategies

4. Cardiac AI Monitoring And Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cardiac AI Monitoring And Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cardiac AI Monitoring And Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cardiac AI Monitoring And Diagnostics Market Growth Rate Analysis
  • 5.4. Global Cardiac AI Monitoring And Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cardiac AI Monitoring And Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cardiac AI Monitoring And Diagnostics Total Addressable Market (TAM)

6. Cardiac AI Monitoring And Diagnostics Market Segmentation

  • 6.1. Global Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Diagnostics
  • Cardiac Monitoring
  • 6.2. Global Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Hardware
  • 6.3. Global Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ischemic Heart Diseases Or Coronary Artery Disease (CAD)
  • Cardiac Arrhythmias
  • Ischemic Stroke
  • Other Applications
  • 6.4. Global Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Other End Users
  • 6.5. Global Cardiac AI Monitoring And Diagnostics Market, Sub-Segmentation Of Cardiac Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • ECG Analysis
  • Echocardiography Analysis
  • Cardiac Imaging
  • Biomarker Analysis
  • 6.6. Global Cardiac AI Monitoring And Diagnostics Market, Sub-Segmentation Of Cardiac Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wearable Cardiac Monitors
  • Remote Patient Monitoring Systems
  • Implantable Cardiac Devices
  • Continuous ECG Monitoring Systems

7. Cardiac AI Monitoring And Diagnostics Market Regional And Country Analysis

  • 7.1. Global Cardiac AI Monitoring And Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cardiac AI Monitoring And Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market

  • 8.1. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac AI Monitoring And Diagnostics Market

  • 9.1. China Cardiac AI Monitoring And Diagnostics Market Overview
  • 9.2. China Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac AI Monitoring And Diagnostics Market

  • 10.1. India Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac AI Monitoring And Diagnostics Market

  • 11.1. Japan Cardiac AI Monitoring And Diagnostics Market Overview
  • 11.2. Japan Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac AI Monitoring And Diagnostics Market

  • 12.1. Australia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac AI Monitoring And Diagnostics Market

  • 13.1. Indonesia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac AI Monitoring And Diagnostics Market

  • 14.1. South Korea Cardiac AI Monitoring And Diagnostics Market Overview
  • 14.2. South Korea Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac AI Monitoring And Diagnostics Market

  • 15.1. Western Europe Cardiac AI Monitoring And Diagnostics Market Overview
  • 15.2. Western Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac AI Monitoring And Diagnostics Market

  • 16.1. UK Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac AI Monitoring And Diagnostics Market

  • 17.1. Germany Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac AI Monitoring And Diagnostics Market

  • 18.1. France Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac AI Monitoring And Diagnostics Market

  • 19.1. Italy Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac AI Monitoring And Diagnostics Market

  • 20.1. Spain Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac AI Monitoring And Diagnostics Market

  • 21.1. Eastern Europe Cardiac AI Monitoring And Diagnostics Market Overview
  • 21.2. Eastern Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac AI Monitoring And Diagnostics Market

  • 22.1. Russia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac AI Monitoring And Diagnostics Market

  • 23.1. North America Cardiac AI Monitoring And Diagnostics Market Overview
  • 23.2. North America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac AI Monitoring And Diagnostics Market

  • 24.1. USA Cardiac AI Monitoring And Diagnostics Market Overview
  • 24.2. USA Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac AI Monitoring And Diagnostics Market

  • 25.1. Canada Cardiac AI Monitoring And Diagnostics Market Overview
  • 25.2. Canada Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac AI Monitoring And Diagnostics Market

  • 26.1. South America Cardiac AI Monitoring And Diagnostics Market Overview
  • 26.2. South America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac AI Monitoring And Diagnostics Market

  • 27.1. Brazil Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac AI Monitoring And Diagnostics Market

  • 28.1. Middle East Cardiac AI Monitoring And Diagnostics Market Overview
  • 28.2. Middle East Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac AI Monitoring And Diagnostics Market

  • 29.1. Africa Cardiac AI Monitoring And Diagnostics Market Overview
  • 29.2. Africa Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac AI Monitoring And Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Cardiac AI Monitoring And Diagnostics Market Competitive Landscape
  • 30.2. Cardiac AI Monitoring And Diagnostics Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac AI Monitoring And Diagnostics Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. ZOLL Medical Corporation
  • 31.3. Canon Medical Systems Corporation
  • 31.4. Biotronik SE & Co. KG
  • 31.5. iRhythm Technologies Inc.
  • 31.6. Tempus Labs Inc.
  • 31.7. Viz.ai Inc.
  • 31.8. HeartFlow Inc.
  • 31.9. Aidoc
  • 31.10. Eko Devices Inc.
  • 31.11. CardioFocus Inc.
  • 31.12. Circle Cardiovascular Imaging Inc.
  • 31.13. Ultromics Limited.
  • 31.14. Cathworks
  • 31.15. Medicalgorithmics S.A.

32. Global Cardiac AI Monitoring And Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac AI Monitoring And Diagnostics Market

34. Recent Developments In The Cardiac AI Monitoring And Diagnostics Market

35. Cardiac AI Monitoring And Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Cardiac AI Monitoring And Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cardiac AI Monitoring And Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cardiac AI Monitoring And Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer